HOME >> BIOLOGY >> NEWS
ANU medical researcher wins national award

ANU immunologist Professor Chris Goodnow has been awarded the Commonwealth Health Minister's Award for Excellence in Health and Medical Research for his research in molecular genetics.

Professor Goodnow, the Director of the Australian Phenomics Facility and Head of the Medical Genome Centre at the John Curtin School of Medical Research, said the award recognised a forward-looking medical research program underway at ANU based on a 'roadmap' of the human genome.

"I'm thrilled to have received this prestigious award from the Australian Government - it is not only satisfying for me personally, but it also is added confirmation of a bold strategy being undertaken at ANU to discover the mechanisms of immune regulation," Professor Goodnow said.

"The next decade of medical science will be driven by investigation of the genome sequence, and research at the John Curtin School of Medical Research is already focusing on this area."

Professor Goodnow said that the Federal Government-funded Australian Phenomics Facility will be a driving force in this genome research, with its program for screening hundreds of thousands of gene sequences and making them accessible to medical researchers around the world.

It has already led to a number of breakthroughs at ANU in one of the largest health problems in the community - dysfunction of the immune system. Autoimmune diseases include type 1 diabetes, rheumatoid arthritis, systemic lupus and multiple sclerosis.

"The research program is a clear example of how ANU leads Australian and international research by looking over the horizon and starting new research fields in anticipation of future of developments - in this case anticipating the sequence of the human genome.

"This current work lays out a genetic roadmap for developing ways to prevent or cure diabetes and other autoimmune diseases, which collectively affect one in 20 Australians.

"It looks into genes and gene mechanis
'"/>

Contact: Tim Winkler
tim.winkler@anu.edu.au
61-2-6125-5001
Research Australia
10-Jun-2005


Page: 1 2

Related biology news :

1. New proteomics research promises to revolutionize biomedical discovery
2. New medical implants should react with the body, not seek to be inert
3. Bee researcher at Arizona State University is 1 of 20 new Pew Scholars in the biomedical sciences
4. Methodist, University of Houston, Cornell combine biomedical imaging expertise
5. Research center unites biomedical competitors to fund medical technology development
6. FSU researchers reap $1-million grant to make medical implants safer
7. New Arizona alliance aims to boost technologies for medical diagnostics and human health
8. Yale biophysicist Thomas Steitz receives Gairdner Award for medical research
9. DNA sequence of Rhesus macaque has evolutionary, medical implications
10. 4th International Conference on Ethical Issues in Biomedical Engineering
11. UT Metroplex institutions to collaborate on biomedical research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ANU medical researcher wins national award

(Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
(Date:6/25/2015)... -- According to a new market ... Technology, Material (Optical Prism, Piezoelectric, Capacitive & Adhesives), ... & Geography - Global Forecast to 2014 - ... expected to reach $14,500.07 Million by 2020, at ... 76 market Tables and 109 Figures spread through ...
(Date:6/24/2015)... YORK , June 24, 2015 The ... rate. The major drivers for the market include growth ... number of new drug launches. Over the years, the ... increased. Between 2001 and 2010, the FDA approved 225 ... according to WIPO, Europe accounted ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
(Date:7/1/2015)... 2015   Decision Resources Group finds ... Otezla are its oral administration, alternative mechanism of ... surveyed rheumatologists. Otezla was the first oral therapy ... active psoriatic arthritis in the United ... includes conventional oral treatments including disease-modifying antirheumatic drugs ...
(Date:7/1/2015)... and BANGALORE, India , July 1, ... company that uses next generation sequencing technology to empower ... A. Storrer as chief executive officer. In his ... be responsible for all strategy, business expansion and worldwide ... has served as Strand,s chairman and CEO since its ...
(Date:7/1/2015)... 1, 2015  Axovant Sciences Ltd. (NYSE:  AXON), ... treatment of dementia, today announced that the company ... at 5:45 p.m. EDT following its presentation of ... Conference 2015 (AAIC). The event ... Dr. Lawrence Friedhoff , Chief Development Officer, ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business plan contest will ask ... to innovation in life sciences R&D. The Pistoia Alliance President’s Startup Challenge 2015 will ... and a period of expert mentorship from a senior industry figure drawn from the ...
Breaking Biology Technology:Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
Cached News: